Glaucoma is a progressive eye disease that damages the optic nerve, often due to increased intraocular pressure. Left untreated, it can lead to irreversible vision loss. Modern techniques now offer safer and less invasive ways to control glaucoma.
Minimally Invasive Glaucoma Surgery (MIGS) is one such innovation. It provides effective glaucoma treatment while reducing risks compared with traditional methods, making it a significant step forward in eye pressure management.
Minimally Invasive Glaucoma Surgery is a group of surgical techniques designed to control glaucoma with smaller incisions, less tissue disruption, and faster recovery.
Unlike conventional filtering surgeries, MIGS surgery uses advanced devices to improve fluid drainage from the eye. As a form of minimally invasive eye surgery, it focuses on lowering pressure while preserving natural eye structures whenever possible.
MIGS treatment involves using specialised micro-instruments or tiny stents inserted through tiny openings in the eye. These create new drainage pathways or enhance existing ones, allowing fluid to exit more efficiently.
This supports long-term glaucoma pressure management and prevents damage to the optic nerve. By reducing reliance on drops, eye surgery for glaucoma through MIGS provides patients with an effective, targeted, and safe alternative.
The benefits of MIGS include smaller incisions, quicker healing, and fewer complications. Unlike conventional surgery, which often carries a higher risk of scarring or infection, MIGS vs traditional glaucoma surgery offers a gentler approach.
Patients experience reduced discomfort, shorter recovery times, and a lower chance of side effects. These advantages of MIGS make it a preferred choice for many glaucoma patients who need surgical care.
Candidates for MIGS are typically those with early to moderate stages of glaucoma. Patients who have tried medications or laser therapies without sufficient control may be ideal.
Glaucoma candidates include adults who still have functional outflow pathways and wish to reduce dependence on drops. The best candidates for MIGS are those needing surgical intervention with minimal disruption to their daily lives.
Glaucoma stent surgery utilises tiny implants, such as the iStent procedure or Hydrus microstent, to create permanent channels for fluid drainage. These stents are placed inside the eye’s natural drainage system, lowering pressure safely and effectively. They are particularly helpful when combined with cataract surgery, offering long-term relief with minimal additional risk.
Trabecular meshwork surgery involves bypassing the natural resistance within the eye’s drainage system. With a MIGS trabecular bypass, fluid flows directly into Schlemm’s canal, significantly reducing pressure. This option is often recommended for patients where traditional drops or laser therapy have failed, but surgery must remain minimally invasive.
Before MIGS preparation, patients undergo detailed examinations, including eye pressure checks, gonioscopy, and a review of their medical history. Current medications are assessed, and the target intraocular pressure is discussed.
Patients may be advised to adjust certain drops or avoid specific drugs before the procedure. Clear planning ensures the MIGS surgery preparation stage is safe and smooth.
The MIGS surgery steps are straightforward. Under local anaesthesia, a surgeon makes a very small incision at the corneal edge.
Using advanced micro-instruments, a stent or bypass device is inserted. The MIGS surgical procedure usually takes less than 30 minutes, and patients typically return home the same day.
MIGS recovery is generally faster than with conventional surgery. Most patients notice less discomfort and return to daily activities sooner. The MIGS healing process involves close follow-up to monitor intraocular pressure and eye stability. The overall recovery time after MIGS is often just a few weeks, depending on the individual.
The MIGS healing process involves close follow-up to monitor intraocular pressure and eye stability. The overall recovery time after MIGS is often just a few weeks, depending on the individual.
MIGS aftercare includes using prescribed eye drops to prevent infection or inflammation. Patients should avoid strenuous activities, heavy lifting, or swimming during the first few weeks. Following all post-surgery instructions for MIGS helps ensure successful outcomes and minimises complications.
Most patients resume normal routines within a week. Light office work is often safe after a few days, while exercise may need to be avoided for two to three weeks.
MIGS activity restrictions are temporary, and patients typically return to their normal life routine quickly. Returning to normal life after MIGS is faster compared to traditional glaucoma surgeries.
Although considered safe, MIGS procedures carry risks, including minor bleeding, inflammation, or temporary fluctuations in eye pressure. Rarely, devices may move or additional surgery may be required. Compared with traditional methods, MIGS complications are far less frequent. The overall risks of minimally invasive glaucoma surgery remain low, and outcomes are generally excellent when proper care and follow-up are provided.
There are many reasons to consider choosing MIGS. It offers quick recovery, minimal discomfort, and effective pressure control with fewer risks.
As part of modern glaucoma management, MIGS advantages are well-suited for patients who seek reliable results with minimal downtime. For many, MIGS for eye health is the ideal way to strike a balance between safety and success, highlighting the core benefits of MIGS for patients with glaucoma.
Minimally Invasive Glaucoma Surgery represents an important step in advancing glaucoma care. It offers patients effective pressure reduction with reduced risks and quicker recovery compared with older methods.
The decision to undergo MIGS depends on the stage of glaucoma, overall health, and the results of previous treatments. Patients should consult their ophthalmologist to decide whether MIGS is the best choice among today’s glaucoma surgery options.
MIGS effectively lowers eye pressure but is not a permanent cure. Glaucoma is lifelong, and patients may still require medications or additional monitoring.
Most patients resume light tasks within a few days and return to normal routines within a week. Full recovery depends on individual healing and following the doctor’s MIGS aftercare instructions.
MIGS is best for early to moderate open-angle glaucoma. It may not be suitable for all cases, particularly advanced or complex forms. The final decision regarding the appropriateness of MIGS for a specific patient is made by the treating physician, who assesses the individual’s type of glaucoma, disease severity, and overall eye health
Yes, MIGS surgery can be performed on both eyes, although it is usually not done simultaneously. Surgeons often stage procedures to ensure safety and optimal recovery.
The cost of MIGS treatment varies by hospital, location, and the type of devices used. Insurance or EMI options may help reduce expenses, making glaucoma care more affordable.
MIGS can reduce or eliminate the need for glaucoma drops in some patients, but many may still require medication for optimal eye pressure control.
MIGS is generally less effective for advanced glaucoma. Traditional surgery may be recommended instead. However, MIGS can still be considered in select cases.
If MIGS treatment fails to achieve the desired pressure, doctors may recommend further medications, laser therapy, or traditional glaucoma surgery to protect vision.